A novel hybrid first-line therapy for H. pylori eradication: results of a pilot study

被引：3
|
作者：
De Francesco, Vincenzo [1 ,2 ]
机构：
[1] Univ Foggia, Gastroenterol Sect, Foggia, Italy
[2] Univ Foggia, Dept Med Sci, Foggia, Italy
来源：
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES | 2019年 / 28卷 / 01期
关键词：
D O I：
10.15403/jgld.2014.1121.281.hyb
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：129 / 130
页数：2
相关论文
共 50 条
  • [21] Bismuth, moxifloxacin, tetracycline, lansoprazole quadruple first line therapy for eradication of H. pylori: A prospective study
    Ergul, Bilal
    Kocak, Erdem
    Tas, Adnan
    Filik, Levent
    Koklu, Seyfettin
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2013, 37 (05) : 527 - 529
  • [22] PROGRESS OF THE FIRST-LINE ERADICATION RATE OF H. PYLORI USING TRIPLE THERAPY-MULTI CENTER STUDY IN TOKYO METROPOLITAN AREA
    Kawai, T.
    Takashi, S.
    Tokunga, K.
    Sakaki, N.
    [J]. HELICOBACTER, 2013, 18 : 131 - 131
  • [23] Levofloxacin in First-Line Triple and Sequential Regimens for H. pylori Eradication: Randomized Clinical Trial
    Molina-Infante, J.
    Fernandez-Bermejo, M.
    Perez-Gallardo, B.
    Hernandez-Alonso, M.
    Mateos-Rodriguez, J. M.
    Duenas-Sadornil, C.
    Gonzalez-Garcia, G.
    Gisbert, J. P.
    [J]. HELICOBACTER, 2009, 14 (04) : 398 - 398
  • [24] First-line triple therapy with levofloxacin for Helicobacter pylori eradication
    Gisbert, J. P.
    Fernandez Bermejo, M.
    Molina Infante, J.
    Perez Gallardo, B.
    Prieto Bermejo, A.
    Mateos Rodriguez, J.
    Robledo Andres, P.
    Gonzalez Garcia, G.
    [J]. HELICOBACTER, 2007, 12 (04) : 432 - 432
  • [25] First-line triple therapy with levofloxacin for Helicobacter pylori eradication
    Gisbert, J. P.
    Fernandez-Bermejo, M.
    Molina-Infante, J.
    Perez-Gallardo, B.
    Prieto-Bermejo, A.-B.
    Mateos-Rodriguez, J.-M.
    Robledo-Andres, P.
    Gonzalez-Garcia, G.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2007, 26 (03) : 495 - 500
  • [26] Effectiveness of first-line H. pylori eradication therapy according to the daily statin-use: Analysis of the European Registry on H. pylori Management (Hp-EuReg)
    Caldas, M.
    Perez-Aisa, A.
    Tepes, B.
    Castro-Fernandez, M.
    Bujanda, L.
    Fadeenko, G.
    Lucendo, A. J.
    Vaira, D.
    Jonaitis, L.
    Brglez Jurecic, N.
    Perez-Lasala, J.
    Fernandez-Salazar, L.
    Rodrigo, L.
    Huguet, J.
    Leja, M.
    Areia, M.
    Barrio, J.
    Ortuno, J.
    Alekseenko, S.
    Molina-Infante, J.
    Bogomolov, P.
    Ntouli, V.
    Dominguez-Cajal, M.
    Ruiz-Zorrilla, R.
    Pellicano, R.
    Espada, M.
    Puig, I.
    Nyssen, O. P.
    Megraud, F.
    O'Morain, C.
    Gisbert, J. P.
    [J]. HELICOBACTER, 2020, 25 : 36 - 37
  • [27] 14 DAY-SEQUENTIAL, CONCOMITANT, AND HYBRID THERAPIES FOR FIRST-LINE HELICOBACTER PYLORI (H. PYLORI) ERADICATION: A NETWORK META-ANALYSIS
    Zhao, X.
    Wu, W.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A222 - A222
  • [28] The Trend of Eradication Rates of First-Line Therapy and Second-Line Quadruple Therapy Containing Metronidazole for H. pylori Infection for Recent Five Years
    Park, J.
    Park, S.
    Kim, G.
    Seoul, S.
    Moon, J.
    Jee, S.
    Jung, H.
    Lee, D.
    Kim, J.
    Lee, S.
    [J]. HELICOBACTER, 2009, 14 (04) : 400 - 400
  • [29] Concomitant, sequential, and hybrid therapy for H-pylori eradication: A pilot study
    Zullo, Angelo
    Scaccianoce, Giuseppe
    De Francesco, Vincenzo
    Ruggiero, Valentina
    D'Ambrosio, Pasquale
    Castorani, Luigi
    Bonfrate, Leonilde
    Vannella, Lucy
    Hassan, Cesare
    Portincasa, Piero
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2013, 37 (06) : 647 - 650
  • [30] Hybrid therapy as first-line regimen for Helicobacter Pylori eradication in a high antibiotic resistance area
    Georgopoulos, S. D.
    Papastergiou, V.
    Martinez-Gonzalez, B.
    Xirouchakis, E.
    Mentis, A.
    Sgouras, D.
    Karatapanis, S.
    [J]. HELICOBACTER, 2016, 21 : 140 - 141
12345